Stocks and Investing Stocks and Investing
Fri, July 5, 2024
Wed, July 3, 2024
Tue, July 2, 2024
Mon, July 1, 2024

Josh Schimmer Reiterated (BBIO) at Buy and Held Target at $70 on, Jul 1st, 2024


Published on 2024-10-28 12:11:23 - WOPRAI, Josh Schimmer
  Print publication without navigation


Josh Schimmer of Cantor Fitzgerald, Reiterated "BridgeBio Pharma, Inc." (BBIO) at Buy and Held Target at $70 on, Jul 1st, 2024.

Josh has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Josh's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Josh


  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy with Decreased Target to $42 on, Tuesday, June 25th, 2024
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Thursday, June 20th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $47 on, Tuesday, May 28th, 2024
  • Cory Kasimov of "Evercore ISI Group" Initiated at Buy and Held Target at $50 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $45 on, Wednesday, March 20th, 2024
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $53 on, Tuesday, March 5th, 2024